Provided by Tiger Trade Technology Pte. Ltd.

Pharming Group N.V.

17.33
-0.4700-2.64%
Post-market: 17.330.00000.00%16:10 EDT
Volume:7.70K
Turnover:134.17K
Market Cap:1.22B
PE:433.25
High:17.67
Open:17.49
Low:17.05
Close:17.80
52wk High:21.34
52wk Low:8.03
Shares:70.63M
Float Shares:68.52M
Volume Ratio:0.52
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0400
EPS(LYR):0.0400
ROE:1.02%
ROA:4.55%
PB:4.42
PE(LYR):433.25

Loading ...

Pharming Group Initiated at Buy by Canaccord Genuity

Dow Jones
·
Apr 10

Pharming initiated with a Buy at Canaccord

TIPRANKS
·
Apr 10

Pharming Receives Positive European Committee Opinion for Immunodeficiency Treatment; Shares Up Pre-Bell

MT Newswires Live
·
Mar 27

Pharming Group Price Target Maintained With a $37.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 24

Pharming Says Joenja Received Japanese Approval to Treat APDS

MT Newswires Live
·
Mar 24

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday as Traders React to Oil Supply Risks From Iran Conflict

MT Newswires Live
·
Mar 12

Pharming Group NV reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 12

Pharming Q4 EPS $0.07 Beats $0.01 Estimate, Sales $106.500M Beat $105.190M Estimate

Benzinga
·
Mar 12

Press Release: Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

Dow Jones
·
Mar 12

Pharming Group NV expected to post earnings of 1 cent a share - Earnings Preview

Reuters
·
Mar 10

Earning Preview: Pharming Group N.V. this quarter’s revenue is expected to increase by 30.28%, and institutional views are bullish

Earnings Agent
·
Mar 05

Pharming Group Issues 2026 Revenue Guidance; Shares Up Pre-Bell

MT Newswires Live
·
Feb 03

Pharming Group Down Nearly 17%, on Pace for Largest Percent Decrease Since September 2023 -- Data Talk

Dow Jones
·
Feb 03

Pharming Group (PHAR) Receives a Buy from Oppenheimer

TIPRANKS
·
Feb 02

Pharming Receives Complete Response Letter From FDA for Pediatric Immune Disorder Drug

MT Newswires Live
·
Feb 02

Pharming Group (PHAR) Receives a Buy from H.C. Wainwright

TIPRANKS
·
Jan 28

Pharming Group Nv : Jefferies Raises Target Price to $23.4 From $19.5

THOMSON REUTERS
·
Jan 09

Pharming Group Reports Upbeat Preliminary 2025 Revenue

MT Newswires Live
·
Jan 08

Stock Track | Pharming Group N.V. Soars 8.93% on Strong Q3 Results and Raised FY25 Guidance

Stock Track
·
Nov 13, 2025

Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday

Benzinga_recent_news
·
Nov 13, 2025